hero banner

Zenrelia (ilunocitinib) Tablets for Dogs Rx

By Zenrelia

Usually shipped in 1-3 business days.* Learn more

Big Savings on Triple Protection!
Save up to 40% with AutoShip

$30 max savings.

Zenrelia (ilunocitinib) Tablets for Dogs Rx

By Zenrelia
$2.18
One-time purchase
$1.31 AutoShip & Save up to 40%
Availability:
  • In Stock

Prescription needed

We'll collect your vet's information at checkout to verify the prescription.

Strength:
Count:
Strength:
Count:
AutoShip & Save 40%
Save 40% on your 1st AutoShip order and 5% on all future AutoShip orders Learn more
  • Save 5% on Future Shipments
  • Free Shipping Over $30
  • Change, Skip, or Cancel Anytime
  • Convenient Automatic Delivery

With AutoShip, we remember so you don’t have to! Learn more

Sorry, there is a back order on this item

Usually shipped in 1-3 business days.* Learn more

Big Savings on Triple Protection!
Save up to 40% with AutoShip

$30 max savings.

Product Overview

Zenrelia is a JAK-inhibitor, that is highly rated by vets and pet owners, for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Zenrelia is a flavorless, oral tablet given once daily with or without food, from the comfort of home.

Indications
Zenrelia is a prescription medication used to control itching and inflammation associates with skin allergies for dogs over 12 months of age.

IMPORTANT SAFETY INFORMATION
See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1-88-545-5973, or visit www.elancolabels.com/us/zenrelia.

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.

Dogs (12 months of age or older)
Innovative treatment, with once daily dosing from the start. Works fast, visible improvements from day one. Continuous Efficacy: No rebound itch due to changing doses. In a head to head clinical trial with Apoquel, 77% of Zenrelia-treated dogs achieved PVAS <2 compared to 53% of Apoquel-treated dogs. Reduces inflammation and improves skin lesions.
Zenrelia blocks itch signals from reaching your dog's brain, reducing the sensation of itch.
Monitor your pet for any adverse reactions, includeing vomiting, diahrea and lethargy. Contact your veterinarian with any quesitons you might have.
ilunocitinib
Contact your nearest emergency animal hospital.
IMPORTANT SAFETY INFORMATION: See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://www.elancolabels.com/us/zenrelia. WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.
Sold in strengths of 4.8 mg, 6.4 mg, 8.5 mg or 15 mg in 1 count, 30 count bottle or 90 count bottle.
Elanco
Use as directed by your Veterinarian.
Active Ingredient : ilunocitinib

You may also like

One-time purchase $19.49
One-time purchase $10.99 - $15.49
One-time purchase $12.99
One-time purchase $131.99
Save Up to 35% on Your First AutoShip
Veterinary Diet Item
One-time purchase $137.99
Save Up to 35% on Your First AutoShip
Veterinary Diet Item
Zenrelia (ilunocitinib) Tablets for Dogs Description
Zenrelia is a JAK-inhibitor, that is highly rated by vets and pet owners, for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Zenrelia is a flavorless, oral tablet given once daily with or without food, from the comfort of home.

Indications
Zenrelia is a prescription medication used to control itching and inflammation associates with skin allergies for dogs over 12 months of age.

IMPORTANT SAFETY INFORMATION
See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1-88-545-5973, or visit www.elancolabels.com/us/zenrelia.

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.

Which animals/pets is Zenrelia (ilunocitinib) Tablets for Dogs for?
Dogs (12 months of age or older)
Zenrelia (ilunocitinib) Tablets for Dogs uses
Innovative treatment, with once daily dosing from the start. Works fast, visible improvements from day one. Continuous Efficacy: No rebound itch due to changing doses. In a head to head clinical trial with Apoquel, 77% of Zenrelia-treated dogs achieved PVAS <2 compared to 53% of Apoquel-treated dogs. Reduces inflammation and improves skin lesions.
What does Zenrelia (ilunocitinib) Tablets for Dogs do?
Zenrelia blocks itch signals from reaching your dog's brain, reducing the sensation of itch.
Zenrelia (ilunocitinib) Tablets for Dogs side effects
Monitor your pet for any adverse reactions, includeing vomiting, diahrea and lethargy. Contact your veterinarian with any quesitons you might have.
Zenrelia (ilunocitinib) Tablets for Dogs ingredients
ilunocitinib
Zenrelia (ilunocitinib) Tablets for Dogs overdose: What to do?
Contact your nearest emergency animal hospital.
What to know before using Zenrelia (ilunocitinib) Tablets for Dogs
IMPORTANT SAFETY INFORMATION: See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://www.elancolabels.com/us/zenrelia. WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.
How is Zenrelia (ilunocitinib) Tablets for Dogs sold?
Sold in strengths of 4.8 mg, 6.4 mg, 8.5 mg or 15 mg in 1 count, 30 count bottle or 90 count bottle.
Manufacturer
Elanco
Overview
Use as directed by your Veterinarian.
Main Ingredients
Active Ingredient : ilunocitinib

Reviews

You may also like

One-time purchase $19.49
One-time purchase $10.99 - $15.49
One-time purchase $12.99
One-time purchase $131.99
Save Up to 35% on Your First AutoShip
Veterinary Diet Item
One-time purchase $137.99
Save Up to 35% on Your First AutoShip
Veterinary Diet Item